Immunotherapy

Home
About
Help
History (1)
- Immunotherapy
- See All Pages

"Immunotherapy" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

Manipulation of the host's immune system in treatment of disease. It includes both active and passive immunization as well as immunosuppressive therapy to prevent graft rejection.

Descriptor ID	D007167
MeSH Number(s)	E02.095.465.425
Concept/Terms	Immunotherapy Immunotherapy Immunotherapies

Below are MeSH descriptors whose meaning is more general than "Immunotherapy".

Analytical, Diagnostic and Therapeutic Techniques and Equipment [E]
Therapeutics [E02]
Biological Therapy [E02.095]
Immunomodulation [E02.095.465]
Immunotherapy [E02.095.465.425]

Below are MeSH descriptors whose meaning is related to "Immunotherapy".

Below are MeSH descriptors whose meaning is more specific than "Immunotherapy".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Immunotherapy" by people in this website by year, and whether "Immunotherapy" was a major or minor topic of these publications.

Bar chart showing 163 publications over 27 distinct years, with a maximum of 27 publications in 2020

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1996	0	3	3
1997	1	1	2
1998	1	1	2
1999	0	1	1
2000	0	3	3
2001	0	1	1
2002	1	1	2
2003	3	3	6
2004	0	2	2
2005	2	0	2
2006	2	6	8
2007	0	4	4
2008	0	1	1
2009	1	1	2
2010	0	1	1
2011	1	1	2
2012	0	3	3
2013	2	1	3
2014	6	2	8
2015	2	2	4
2016	9	5	14
2017	9	4	13
2018	9	5	14
2019	9	3	12
2020	9	18	27
2021	1	9	10
2022	2	11	13

Below are the most recent publications written about "Immunotherapy" by people in Profiles.

Sklavenitis-Pistofidis R, Aranha MP, Redd RA, Baginska J, Haradhvala NJ, Hallisey M, Dutta AK, Savell A, Varmeh S, Heilpern-Mallory D, Ujwary S, Zavidij O, Aguet F, Su NK, Lightbody ED, Bustoros M, Tahri S, Mouhieddine TH, Wu T, Flechon L, Anand S, Rosenblatt JM, Zonder J, Vredenburgh JJ, Boruchov A, Bhutani M, Usmani SZ, Matous J, Yee AJ, Jakubowiak A, Laubach J, Manier S, Nadeem O, Richardson P, Badros AZ, Mateos MV, Trippa L, Getz G, Ghobrial IM. Immune biomarkers of response to immunotherapy in patients with high-risk smoldering myeloma. Cancer Cell. 2022 11 14; 40(11):1358-1373.e8.

View in: PubMed
Molina-Cerrillo J, Santoni M, Ruiz ?, Massari F, Pozas J, Ortego I, G?mez V, Grande E, Alonso-Gordoa T. Epigenetics in advanced renal cell carcinoma: Potential new targets. Crit Rev Oncol Hematol. 2022 Dec; 180:103857.

View in: PubMed
Huang K, Liu X, Han G, Zhou Y. Nano-optogenetic immunotherapy. Clin Transl Med. 2022 09; 12(9):e1020.

View in: PubMed
Monticone G, Huang Z, Csibi F, Leit S, Ciccone D, Champhekar AS, Austin JE, Ucar DA, Hossain F, Ibba SV, Boulares AH, Carpino N, Xu K, Majumder S, Osborne BA, Loh C, Miele L. Targeting the Cbl-b-Notch1 axis as a novel immunotherapeutic strategy to boost CD8+ T-cell responses. Front Immunol. 2022; 13:987298.

View in: PubMed
Varlotto JM, Sun Z, Ky B, Upshaw J, Fitzgerald TJ, Diehn M, Lovly C, Belani C, Oettel K, Masters G, Harkenrider M, Ross H, Ramalingam S, Pennell NA. A Review of Concurrent Chemo/Radiation, Immunotherapy, Radiation Planning, and Biomarkers for Locally Advanced Non-small Cell Lung Cancer and Their Role in the Development of ECOG-ACRIN EA5181. Clin Lung Cancer. 2022 11; 23(7):547-560.

View in: PubMed
Santoni M, Molina-Cerrillo J, Massari F, Montironi R, Grande E. Re: Effect of Immunotherapy Time-of-day Infusion on Overall Survival Among Patients with Advanced Melanoma in the USA (MEMOIR): A Propensity Score-matched Analysis of a Single-centre, Longitudinal Study. Eur Urol. 2022 06; 81(6):623-624.

View in: PubMed
Kent SC, Zaldumbide A. Editorial: Autoimmune Diabetes: Molecular Mechanisms and Neoantigens. Front Immunol. 2022; 13:864517.

View in: PubMed
Abdelfattah N, Kumar P, Wang C, Leu JS, Flynn WF, Gao R, Baskin DS, Pichumani K, Ijare OB, Wood SL, Powell SZ, Haviland DL, Parker Kerrigan BC, Lang FF, Prabhu SS, Huntoon KM, Jiang W, Kim BYS, George J, Yun K. Single-cell analysis of human glioma and immune cells identifies S100A4 as an immunotherapy target. Nat Commun. 2022 02 09; 13(1):767.

View in: PubMed
Chibaya L, Snyder J, Ruscetti M. Senescence and the tumor-immune landscape: Implications for cancer immunotherapy. Semin Cancer Biol. 2022 11; 86(Pt 3):827-845.

View in: PubMed
Atukorale PU, Moon TJ, Bokatch AR, Lusi CF, Routhier JT, Deng VJ, Karathanasis E. Dual agonist immunostimulatory nanoparticles combine with PD1 blockade for curative neoadjuvant immunotherapy of aggressive cancers. Nanoscale. 2022 Jan 27; 14(4):1144-1159.

View in: PubMed

People

Explore

Similar Concepts

Top Journals